BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AbD Serotec 

3200 Atlantic Avenue
Suite 125
Raleigh  North Carolina  27604  U.S.A.
Phone: 919-878-7978 Fax: 919-878-3751


SEARCH JOBS










 Company News
Bio-Rad Laboratories, Inc. (BIO) Acquires AbD Serotec for $69 Million Cash 1/10/2013 7:43:56 AM
Bio-Rad Laboratories, Inc. (BIO) to Buy AbD Serotec for $69.8 Million 12/17/2012 7:15:01 AM
AbD Serotec Licenses HuCAL Antibodies to DiaSorin Inc. for Use in Clinical Diagnostic Assays for Infectious Disease Testing 10/16/2012 9:33:43 AM
AbD Serotec Introduces Bovine and Ovine Dendritic Cell Growth Kits and Antibodies 7/10/2012 10:10:17 AM
AbD Serotec to Launch Panel of HuCAL Anti-Drug Antibodies Supporting the Development of Novel Antibody Therapeutics 5/23/2012 9:11:19 AM
AbD Serotec Expands Range of HuCAL Antibodies Used in Clinical Diagnostic Kits 3/15/2012 8:24:13 AM
MorphoSys AG: AbD Serotec, Moredun Research Institute and Roslin Institute Announce Grant Funding to Establish Veterinary Research Reagents 10/12/2011 8:21:15 AM
AbD Serotec and Merck & Co., Inc. (MRK) Sign License Agreement for Use of HuCAL GOLD in Vaccine Research 8/1/2011 8:42:08 AM
AbD Serotec Signs Agreement with Dana-Farber Cancer Institute for Anti- Infective Research 7/25/2011 7:01:15 AM
AbD Serotec Licenses Seven Diagnostic HuCAL Antibodies to Proteomika to Monitor Biologics Therapies 5/16/2011 9:12:05 AM
123